|
|
|
Volumn 6, Issue 6, 2004, Pages
|
|
Infliximab therapy in rheumatoid arthritis and ankylosing spondylitis-induced specific antinuclear and antiphospholipid autoantibodies without autoimmune clinical manifestations: a two-year prospective study.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINUCLEAR ANTIBODY;
AUTOANTIGEN;
BETA2 GLYCOPROTEIN 1;
DNA;
GLYCOPROTEIN;
IMMUNOGLOBULIN G;
IMMUNOGLOBULIN M;
IMMUNOSUPPRESSIVE AGENT;
INFLIXIMAB;
METHOTREXATE;
MONOCLONAL ANTIBODY;
NONSTEROID ANTIINFLAMMATORY AGENT;
PHOSPHOLIPID ANTIBODY;
TUMOR NECROSIS FACTOR ALPHA;
ANKYLOSING SPONDYLITIS;
ARTICLE;
AUTOIMMUNE DISEASE;
AUTOIMMUNITY;
BIOSYNTHESIS;
BLOOD;
DRUG ANTAGONISM;
DRUG EFFECT;
FOLLOW UP;
HUMAN;
IMMUNOLOGY;
PROSPECTIVE STUDY;
RHEUMATOID ARTHRITIS;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ANTIBODIES, ANTINUCLEAR;
ANTIBODIES, ANTIPHOSPHOLIPID;
ANTIBODIES, MONOCLONAL;
ARTHRITIS, RHEUMATOID;
AUTOANTIGENS;
AUTOIMMUNE DISEASES;
AUTOIMMUNITY;
BETA 2-GLYCOPROTEIN I;
DNA;
FOLLOW-UP STUDIES;
GLYCOPROTEINS;
HUMANS;
IMMUNOGLOBULIN G;
IMMUNOGLOBULIN M;
IMMUNOSUPPRESSIVE AGENTS;
METHOTREXATE;
PROSPECTIVE STUDIES;
SPONDYLITIS, ANKYLOSING;
TUMOR NECROSIS FACTOR-ALPHA;
|
|
EID: 16344383360
PISSN: None
EISSN: 14786362
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (108)
|
|
References (0)
|
